Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co IncfiledCriticalMerck and Co Inc
Priority to ES299357ApriorityCriticalpatent/ES299357A1/en
Publication of ES299357A1publicationCriticalpatent/ES299357A1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Process for producing substituted guanidine compounds, wherein a levialkyl ester of 3-amino-6-substituted-pyrazinoic acid is reacted with a guanidine to obtain a (3-amino-6-substituted-pyrazinoyl) -guanidine, in the that the 6-substituent is selected from the group consisting of levyalkyl, levyalkylthio, levyalkylsulphonyl, mononuclear aryl, and amino radicals. (Machine-translation by Google Translate, not legally binding)
ES299357A1964-04-231964-04-23Procedure to produce replaced guanidine compounds (Machine-translation by Google Translate, not legally binding)
ExpiredES299357A1
(en)
A procedure to produce eter 3,3-bis- (alpha, gamma - dihydroxy - beta, beta-dimethylbutirilamino) - dipropilic. (Machine-translation by Google Translate, not legally binding)
Procedure for the monohydration of the equimolecular complex formed by ascorbic acid and pyridoxine. (Machine-translation by Google Translate, not legally binding)